Romosozumab Reduces Incidence of New Vertebral Fractures Across Severity Grades Among Postmenopausal Women with Osteoporosis
出版年份 2021 全文链接
标题
Romosozumab Reduces Incidence of New Vertebral Fractures Across Severity Grades Among Postmenopausal Women with Osteoporosis
作者
关键词
Osteoporosis, Anabolics, Clinical trials
出版物
BONE
Volume -, Issue -, Pages 116209
出版商
Elsevier BV
发表日期
2021-09-20
DOI
10.1016/j.bone.2021.116209
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update
- (2020) Dolores Shoback et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Distribution of Prevalent and Incident Vertebral Fractures and Their Association with Bone Mineral Density in Postmenopausal Women in the Teriparatide Versus Risedronate VERO Clinical Trial
- (2020) Piet Geusens et al. CALCIFIED TISSUE INTERNATIONAL
- ANABOLIC THERAPY AND OPTIMAL TREATMENT SEQUENCES FOR PATIENTS WITH OSTEOPOROSIS AT HIGH RISK FOR FRACTURE
- (2020) Felicia Cosman Endocrine Practice
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS— 2020 UPDATE EXECUTIVE SUMMARY
- (2020) Pauline M. Camacho et al. Endocrine Practice
- Teriparatide versus bisphosphonates for treatment of postmenopausal osteoporosis: A meta-analysis
- (2019) Fei Yuan et al. International Journal of Surgery
- Risk of imminent fracture following a previous fracture in a Swedish database study
- (2019) J. Banefelt et al. OSTEOPOROSIS INTERNATIONAL
- Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture Outcome
- (2018) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Vertebral Fracture: Diagnostic Difficulties of a Major Medical Problem
- (2018) Pawel Szulc JOURNAL OF BONE AND MINERAL RESEARCH
- Adding Lateral Spine Imaging for Vertebral Fractures to Densitometric Screening: Improving Ascertainment of Patients at High Risk of Incident Osteoporotic Fractures
- (2018) Richard L Prince et al. JOURNAL OF BONE AND MINERAL RESEARCH
- One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study
- (2018) E Michael Lewiecki et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vertebral Fractures: Clinical Importance and Management
- (2016) D.L. Kendler et al. AMERICAN JOURNAL OF MEDICINE
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiresorptive therapies for osteoporosis: a clinical overview
- (2011) Jian Sheng Chen et al. Nature Reviews Endocrinology
- Height loss, vertebral fractures, and the misclassification of osteoporosis
- (2010) WanWan Xu et al. BONE
- Vertebral fracture assessment using a semiquantitative technique
- (2010) Harry K. Genant et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
- (2010) Desmond Padhi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Vertebral Fracture Status and the World Health Organization Risk Factors for Predicting Osteoporotic Fracture Risk*
- (2008) Peiqi Chen et al. JOURNAL OF BONE AND MINERAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation